DK0668292T3 - Fremgangsmåde til udvinding af insulin med korrekt forbundne - Google Patents

Fremgangsmåde til udvinding af insulin med korrekt forbundne

Info

Publication number
DK0668292T3
DK0668292T3 DK95101748T DK95101748T DK0668292T3 DK 0668292 T3 DK0668292 T3 DK 0668292T3 DK 95101748 T DK95101748 T DK 95101748T DK 95101748 T DK95101748 T DK 95101748T DK 0668292 T3 DK0668292 T3 DK 0668292T3
Authority
DK
Denmark
Prior art keywords
insulin
arg
peptide
lys
protein
Prior art date
Application number
DK95101748T
Other languages
Danish (da)
English (en)
Inventor
Rainer Dr Obermeier
Martin Dr Gerl
Juergen Ludwig
Walter Sabel
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Application granted granted Critical
Publication of DK0668292T3 publication Critical patent/DK0668292T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C07K1/1133—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by redox-reactions involving cystein/cystin side chains
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK95101748T 1994-02-18 1995-02-09 Fremgangsmåde til udvinding af insulin med korrekt forbundne DK0668292T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4405179A DE4405179A1 (de) 1994-02-18 1994-02-18 Verfahren zur Gewinnung von Insulin mit korrekt verbundenen Cystinbrücken

Publications (1)

Publication Number Publication Date
DK0668292T3 true DK0668292T3 (da) 1998-11-23

Family

ID=6510552

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95101748T DK0668292T3 (da) 1994-02-18 1995-02-09 Fremgangsmåde til udvinding af insulin med korrekt forbundne

Country Status (15)

Country Link
US (1) US5663291A (fr)
EP (1) EP0668292B1 (fr)
JP (1) JP3863579B2 (fr)
KR (1) KR100371824B1 (fr)
AT (1) ATE166069T1 (fr)
AU (1) AU699817B2 (fr)
CA (1) CA2142780C (fr)
DE (2) DE4405179A1 (fr)
DK (1) DK0668292T3 (fr)
ES (1) ES2119241T3 (fr)
FI (1) FI115916B (fr)
HK (1) HK1010457A1 (fr)
IL (1) IL112680A0 (fr)
NO (1) NO318424B1 (fr)
SG (1) SG46683A1 (fr)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0821006T3 (da) 1996-07-26 2004-08-16 Aventis Pharma Gmbh Insulinderivater med öget zinkbinding
DE19726167B4 (de) 1997-06-20 2008-01-24 Sanofi-Aventis Deutschland Gmbh Insulin, Verfahren zu seiner Herstellung und es enthaltende pharmazeutische Zubereitung
DE19735711C2 (de) 1997-08-18 2001-04-26 Aventis Pharma Gmbh Verfahren zur Herstellung eines Vorläufers von Insulin oder Insulinderivaten mit korrekt verbundenen Cystinbrücken
DE19825447A1 (de) 1998-06-06 1999-12-09 Hoechst Marion Roussel De Gmbh Neue Insulinanaloga mit erhöhter Zinkbildung
DE19838097A1 (de) 1998-08-24 2000-03-02 Hoechst Marion Roussel De Gmbh Verfahren zur chromatographischen Reinigung von Insulinen
FI107115B (fi) 1998-09-30 2001-06-15 Valio Oy Menetelmä naudan insuliinin poistamiseksi
DE59810555D1 (de) 1998-10-09 2004-02-12 Scil Proteins Gmbh Verfahren zur Gewinnung von aktivem Beta-NGF
JP3406244B2 (ja) 1999-04-30 2003-05-12 伊藤ハム株式会社 新規な融合蛋白質からの組み換えインスリンの製造方法
US6746853B1 (en) 1999-05-19 2004-06-08 Xencor, Inc. Proteins with insulin-like activity useful in the treatment of diabetes
DE19930676B4 (de) * 1999-07-02 2006-01-19 Sanofi-Aventis Deutschland Gmbh Verfahren zur Stabilisierung von Insulin, Insulinderivaten und/oder deren Vorläufer in komplexen Mischungen bei deren Lagerung in wäßrigen Lösungsmitteln
AR025646A1 (es) * 2000-09-13 2002-12-04 Beta Lab Sa Cepa de levaduras metilotroficas recombinantes productoras de un precursor de insulina, construcciones de adn y metodo para obtener la cepa.
DE10114178A1 (de) 2001-03-23 2002-10-10 Aventis Pharma Gmbh Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität
AU2002316807A1 (en) * 2001-06-08 2002-12-23 Novo Nordisk A/S Method for making insulin precursors and insulin precursor analogs
DE10227232A1 (de) * 2002-06-18 2004-01-15 Aventis Pharma Deutschland Gmbh Saure Insulinzubereitungen mit verbesserter Stabilität
US7193035B2 (en) * 2002-10-29 2007-03-20 Sanofi-Aventis Deutschland Gmbh Crystals of insulin analogs and processes for their preparation
ES2337684T3 (es) * 2003-12-05 2010-04-28 F. Hoffmann-La Roche Ag Carboxipeptidasa b recombinante y su purificacion.
DE102004015965A1 (de) * 2004-04-01 2005-10-20 Aventis Pharma Gmbh Verfahren zur Gewinnung von Insulinen durch verbesserte Luftbegasung der Faltung
DE102006031955A1 (de) 2006-07-11 2008-01-17 Sanofi-Aventis Deutschland Gmbh Verfahren zur Herstellung von Insulinanaloga mit dibasischem B-Kettenende
DE102006031962A1 (de) * 2006-07-11 2008-01-17 Sanofi-Aventis Deutschland Gmbh Amidiertes Insulin Glargin
RU2495131C2 (ru) * 2008-02-19 2013-10-10 Байокон Лимитид Способ получения рекомбинантного инсулина гларгина
WO2009133529A2 (fr) * 2008-04-30 2009-11-05 Wockhardt Research Centre Procédés pour le repliement de l’insuline
PL219335B1 (pl) * 2008-07-04 2015-04-30 Inst Biotechnologii I Antybiotyków Pochodna insuliny lub jej farmaceutycznie dopuszczalna sól, jej zastosowanie oraz zawierająca ją kompozycja farmaceutyczna
HUE037449T2 (hu) 2008-10-17 2018-08-28 Sanofi Aventis Deutschland Egy inzulin és egy GLP-1 agonista kombinációja
UA91281C2 (ru) * 2008-11-26 2010-07-12 Общество С Ограниченной Ответственностью «Мако» Способ получения рекомбинантного инсулина человека
WO2011058082A1 (fr) 2009-11-13 2011-05-19 Sanofi-Aventis Deutschland Gmbh Composition pharmaceutique comprenant un agoniste de glp-1 et de la méthionine
AR080669A1 (es) 2009-11-13 2012-05-02 Sanofi Aventis Deutschland Composicion farmaceutica que comprende un agonista de glp-1, una insulina y metionina
ES2606554T3 (es) 2010-08-30 2017-03-24 Sanofi-Aventis Deutschland Gmbh Uso de AVE0010 para la fabricación de un medicamento para el tratamiento de la diabetes mellitus de tipo 2
BR112013025151B1 (pt) 2011-04-01 2021-09-28 3M Innovative Properties Company Laminação retrorrefletiva
EP2739646B1 (fr) * 2011-05-10 2018-01-24 Stefan Hermann Système tampon complet pour la renaturation de la pro-insuline humaine ou de dérivés de pro-insuline humaine
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
BR112014004726A2 (pt) 2011-08-29 2017-04-04 Sanofi Aventis Deutschland combinação farmacêutica para uso no controle glicêmico em pacientes de diabetes tipo 2
TWI559929B (en) 2011-09-01 2016-12-01 Sanofi Aventis Deutschland Pharmaceutical composition for use in the treatment of a neurodegenerative disease
WO2014099577A1 (fr) 2012-12-17 2014-06-26 Merck Sharp & Dohme Corp. Procédé pour purifier l'insuline et ses analogues
WO2015138548A1 (fr) 2014-03-14 2015-09-17 Merck Sharp & Dohme Corp. Purification de l'insuline au moyen d'un échange de cations et d'une chromatographie en phase inverse en présence d'un modificateur organique et à température élevée
PL3229828T3 (pl) 2014-12-12 2023-07-31 Sanofi-Aventis Deutschland Gmbh Formulacja o ustalonym stosunku insuliny glargine/liksysenatydu
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患之治療
EP3344651B1 (fr) 2015-09-02 2022-03-02 Merck Sharp & Dohme Corp. Procédé d'obtention d'insuline avec liaisons disulfure correctement formées

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU76881A (en) * 1980-03-27 1984-04-30 Lilly Co Eli Process for obtaining insulin precursors
NZ199391A (en) * 1981-01-02 1985-12-13 Genentech Inc Chimeric polypeptides comprising a proinsulin sequence,and preparation by recombinant dna technique;production of human insulin
US4616078A (en) * 1985-04-08 1986-10-07 Eli Lilly And Company Process for purifying proinsulin-like materials
DE3537708A1 (de) * 1985-10-23 1987-04-23 Boehringer Mannheim Gmbh Verfahren zur aktivierung von t-pa nach expression in prokaryonten
US4877868A (en) * 1986-03-12 1989-10-31 Neorx Corporation Radionuclide antibody coupling
DE4012818A1 (de) * 1990-04-21 1991-10-24 Hoechst Ag Verfahren zur herstellung von fremdproteinen in streptomyceten
DE58906966D1 (de) * 1988-06-23 1994-03-24 Hoechst Ag Mini-Proinsulin, seine Herstellung und Verwendung.
DE3901718A1 (de) * 1989-01-21 1990-07-26 Hoechst Ag Verfahren zur renaturierung falscher rekombinanten von insulinvorlaeufern
IL95495A (en) * 1989-08-29 1996-10-16 Hoechst Ag Fusion proteins their preparation and use
DE4028120C2 (de) * 1990-09-05 1996-09-19 Hoechst Ag Verfahren zur Reinigung von Insulin und/oder Insulinderivaten
US5231178A (en) * 1991-01-16 1993-07-27 The Salk Institute Biotechnology/Industrial Associates, Inc. Method for the purification of intact, correctly-folded insulin-like growth factor-1
EP0599303A3 (fr) * 1992-11-27 1998-07-29 Takeda Chemical Industries, Ltd. Conjugués peptidiques
DK0600372T3 (da) * 1992-12-02 1997-08-11 Hoechst Ag Fremgangsmåde til fremstilling af proinsulin med korrekt forbundne cystinbroer.
US5523293A (en) * 1994-05-25 1996-06-04 Iowa State University Research Foundation, Inc. Soy protein-based thermoplastic composition for preparing molded articles

Also Published As

Publication number Publication date
EP0668292A3 (fr) 1996-02-07
IL112680A0 (en) 1995-05-26
SG46683A1 (en) 1998-02-20
HK1010457A1 (en) 1999-06-17
ATE166069T1 (de) 1998-05-15
FI115916B (fi) 2005-08-15
US5663291A (en) 1997-09-02
FI950699A (fi) 1995-08-19
KR950032282A (ko) 1995-12-20
NO950592L (no) 1995-08-21
CA2142780C (fr) 2008-10-14
AU699817B2 (en) 1998-12-17
FI950699A0 (fi) 1995-02-16
NO318424B1 (no) 2005-04-18
AU1228895A (en) 1995-08-31
CA2142780A1 (fr) 1995-08-19
EP0668292A2 (fr) 1995-08-23
ES2119241T3 (es) 1998-10-01
JP3863579B2 (ja) 2006-12-27
EP0668292B1 (fr) 1998-05-13
JPH07265092A (ja) 1995-10-17
DE4405179A1 (de) 1995-08-24
DE59502138D1 (de) 1998-06-18
NO950592D0 (no) 1995-02-17
KR100371824B1 (ko) 2003-04-10

Similar Documents

Publication Publication Date Title
DK0668292T3 (da) Fremgangsmåde til udvinding af insulin med korrekt forbundne
KR100537842B1 (ko) 정확하게 결합된 시스틴 브릿지를 갖는 인슐린 전구체를 수득하는 방법
FI108727B (fi) Menetelmä oikein sitoutuneet kystiinisillat omaavan proinsuliinin saamiseksi
DE69929805D1 (de) Modifiziertes e.coli enterotoxin ii signalpeptid sowie ein mikroorganismus der ein fusionsprotein sowie ein heterologes protein exprimiert
DE3477004D1 (en) Process for the preparation of insuline derivatives
DK365484A (da) Fremgangsmaade til fremstilling af polypeptider med endestillet carboxylsyreamidcarboxy
ATE381619T1 (de) Verfahren zur herstellung von rekombinantem insulin durch fusionsproteine
ATE290088T1 (de) Verfahren zur spaltung eines chimeren proteins mittels eines 'processing'-enzyms
NZ196609A (en) Preparation of proinsulin-like insulin precursors
Gattner et al. Enzyme-catalysed semi-synthesis with insulin derivatives
DE69428401D1 (de) Verfahren zur Herstellung von alpha-Aminosäureamiden zur Verwendung in der Peptidsynthese